An exploratory study on the effect of kynurenine metabolites on sEnd‐2 endothelioma cells

Abstract

AbstractCancer is the second leading cause of mortality worldwide. The development of anticancer therapy plays a crucial role in mitigating tumour progression and metastasis. Epithelioid hemangioendothelioma is a very rare cancer, however, with a high systemic involvement. Kynurenine metabolites which include l‐kynurenine, 3‐hydroxykynurenine, 3‐hydroxyanthranilic acid and quinolinic acid have been shown to inhibit T‐cell proliferation resulting in a decrease in cell growth of natural killer cells and T cells. Furthermore, metabolites such as  l‐kynurenine have been shown to inhibit proliferation of melanoma cells in vitro. Considering these metabolite properties, the present study aimed to explore the in vitro effects of  l‐kynurenine, quinolinic acid and kynurenic acid on endothelioma sEnd‐2 cells and on endothelial (EA. hy926 cells) (control cell line). The in vitro effect at 24, 48, and 72 h exposure to a range of 1−4 mM of the respective kynurenine metabolites on the two cell lines in terms of cell morphology, cell cycle progression and induction of apoptosis was assessed. The half inhibitory concentration (IC50), as determined using nonlinear regression, for  l‐kynurenine, quinolinic acid and kynurenic acid was 9.17, 15.56, and 535.40 mM, respectively. Optical transmitted light differential interference contrast and hematoxylin and eosin staining revealed cells blocked in metaphase, formation of apoptotic bodies and compromised cell density in  l‐kynurenine‐treated cells. A statistically significant increase in the number of cells present in the sub‐G1 phase was observed in  l‐kynurenine‐treated sample. To our knowledge, this was the first in vitro study conducted to investigate the mechanism of action of kynurenine metabolites on endothelioma sEnd‐2 cells. It can be concluded that  l‐kynurenine exerts an antiproliferative effect on the endothelioma sEnd‐2 cell line by decreasing cell growth and proliferation as well as a metaphase block. These hallmarks suggest cell death via apoptosis. Further research will be conducted on  l‐kynurenine to assess the effect on cell adhesion in vitro and in vivo as cell‐cell adhesion has been shown to increase metastasis to distant organs therefore, the inhibition of adhesion may lead to a decrease in metastasis.